Correction to: Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1758-9193

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Correction to: Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline ; volume:10 ; number:1 ; day:20 ; month:6 ; year:2018 ; pages:1-3 ; date:12.2018
Alzheimer's research & therapy ; 10, Heft 1 (20.6.2018), 1-3, 12.2018

Creator: Bos, Isabelle

Contributor: Verhey, Frans R.
Ramakers, Inez H. G. B.
Jacobs, Heidi I. L.
Soininen, Hilkka
Freund-Levi, Yvonne
Hampel, Harald
Tsolaki, Magda
Wallin, Åsa K.
van Buchem, Mark A.
Oleksik, Ania
Verbeek, Marcel M.
Rikkert, Marcel Olde
van der Flier, Wiesje M.
Scheltens, Philip
Aalten, Pauline
Visser, Pieter Jelle
Vos, Stephanie J. B.
SpringerLink (Online service)

DOI: 10.1186/s13195-018-0391-x

URN: urn:nbn:de:101:1-2018083023400550525457

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:29 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Bos, Isabelle
Verhey, Frans R.
Ramakers, Inez H. G. B.
Jacobs, Heidi I. L.
Soininen, Hilkka
Freund-Levi, Yvonne
Hampel, Harald
Tsolaki, Magda
Wallin, Åsa K.
van Buchem, Mark A.
Oleksik, Ania
Verbeek, Marcel M.
Rikkert, Marcel Olde
van der Flier, Wiesje M.
Scheltens, Philip
Aalten, Pauline
Visser, Pieter Jelle
Vos, Stephanie J. B.
SpringerLink (Online service)

Other Objects (12)

Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline

A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future

Heterogeneity of Alzheimer’s disease: consequence for drug trials?

Diagnostic Impact of CSF Biomarkers in a Local Hospital Memory Clinic Revisited

Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies

Unbiased estimates of cerebrospinal fluid β-amyloid 1–42 cutoffs in a large memory clinic population

The “rights” of precision drug development for Alzheimer’s disease

Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light - a randomized clinical trial

Testing Episodic Memory in Elderly Subjects: Not as Simple as It Looks

Plasma oligomer beta-amyloid is associated with disease severity and cerebral amyloid deposition in Alzheimer’s disease spectrum

Steeper memory decline after COVID-19 lockdown measures

Eyes-closed task-free electroencephalography in clinical trials for Alzheimer’s disease: an emerging method based upon brain dynamics

Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline

A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future

Heterogeneity of Alzheimer’s disease: consequence for drug trials?

Diagnostic Impact of CSF Biomarkers in a Local Hospital Memory Clinic Revisited

Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies

Unbiased estimates of cerebrospinal fluid β-amyloid 1–42 cutoffs in a large memory clinic population

The “rights” of precision drug development for Alzheimer’s disease

Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light - a randomized clinical trial

Testing Episodic Memory in Elderly Subjects: Not as Simple as It Looks

Plasma oligomer beta-amyloid is associated with disease severity and cerebral amyloid deposition in Alzheimer’s disease spectrum

Steeper memory decline after COVID-19 lockdown measures

Eyes-closed task-free electroencephalography in clinical trials for Alzheimer’s disease: an emerging method based upon brain dynamics

Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline

A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future

Heterogeneity of Alzheimer’s disease: consequence for drug trials?

Diagnostic Impact of CSF Biomarkers in a Local Hospital Memory Clinic Revisited

Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies

Unbiased estimates of cerebrospinal fluid β-amyloid 1–42 cutoffs in a large memory clinic population

The “rights” of precision drug development for Alzheimer’s disease

Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light - a randomized clinical trial

Testing Episodic Memory in Elderly Subjects: Not as Simple as It Looks

Plasma oligomer beta-amyloid is associated with disease severity and cerebral amyloid deposition in Alzheimer’s disease spectrum

Steeper memory decline after COVID-19 lockdown measures

Eyes-closed task-free electroencephalography in clinical trials for Alzheimer’s disease: an emerging method based upon brain dynamics

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Correction to: Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline

A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future

Heterogeneity of Alzheimer’s disease: consequence for drug trials?

Diagnostic Impact of CSF Biomarkers in a Local Hospital Memory Clinic Revisited

Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies

Unbiased estimates of cerebrospinal fluid β-amyloid 1–42 cutoffs in a large memory clinic population

The “rights” of precision drug development for Alzheimer’s disease

Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light - a randomized clinical trial

Testing Episodic Memory in Elderly Subjects: Not as Simple as It Looks

Plasma oligomer beta-amyloid is associated with disease severity and cerebral amyloid deposition in Alzheimer’s disease spectrum

Steeper memory decline after COVID-19 lockdown measures

Eyes-closed task-free electroencephalography in clinical trials for Alzheimer’s disease: an emerging method based upon brain dynamics

Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline

A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future

Heterogeneity of Alzheimer’s disease: consequence for drug trials?

Diagnostic Impact of CSF Biomarkers in a Local Hospital Memory Clinic Revisited

Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies

Unbiased estimates of cerebrospinal fluid β-amyloid 1–42 cutoffs in a large memory clinic population

The “rights” of precision drug development for Alzheimer’s disease

Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light - a randomized clinical trial

Testing Episodic Memory in Elderly Subjects: Not as Simple as It Looks

Plasma oligomer beta-amyloid is associated with disease severity and cerebral amyloid deposition in Alzheimer’s disease spectrum

Steeper memory decline after COVID-19 lockdown measures

Eyes-closed task-free electroencephalography in clinical trials for Alzheimer’s disease: an emerging method based upon brain dynamics

Cerebrovascular and amyloid pathology in predementia stages: the relationship with neurodegeneration and cognitive decline

A decade of Alzheimer’s Research & Therapy: reflections on the past, present, and future

Heterogeneity of Alzheimer’s disease: consequence for drug trials?

Diagnostic Impact of CSF Biomarkers in a Local Hospital Memory Clinic Revisited

Amyloid-β peptides in cerebrospinal fluid of patients with dementia with Lewy bodies

Unbiased estimates of cerebrospinal fluid β-amyloid 1–42 cutoffs in a large memory clinic population

The “rights” of precision drug development for Alzheimer’s disease

Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light - a randomized clinical trial

Testing Episodic Memory in Elderly Subjects: Not as Simple as It Looks

Plasma oligomer beta-amyloid is associated with disease severity and cerebral amyloid deposition in Alzheimer’s disease spectrum

Steeper memory decline after COVID-19 lockdown measures

Eyes-closed task-free electroencephalography in clinical trials for Alzheimer’s disease: an emerging method based upon brain dynamics

Related objects

Reset password